ALK gene | sciencenewsnet.in

Breaking News

New research shows that organizations must address relationships between nurses and key stakeholders for them to thrive and stay in the profession

New York Aquarium Unveils Powerful ‘Washed Ashore’ Experience To Raise Awareness About Ocean Plastic Pollution

New research shows that organizations must address relationships between nurses and key stakeholders for them to thrive and stay in the profession

Program announced for NUTRITION 2024 to be held June 29–July 2

Foreign substance inhalation accidents in infants and young children can immediately be resolved by using an endoscopic robot

Four state-of-the-art, artificial intelligence search engines for histopathology images may not be ready for clinical use

When Working Out, Males Are Programmed to Burn More Fat, while Females Recycle It—at Least in Rats

Getting Under the Skin at May 11 Symposium on Melanoma

Researchers Discover Key Functions of Therapeutically Promising Jumbo Viruses

Cost-effective, high-capacity, and cyclable lithium-ion battery cathodes

02 May, 2024

Researchers Show Lorlatinib is Safe and Effective for Patients with ALK-Driven Relapsed/Refractory High-Risk Neuroblastoma

April 3, 2023 sarah JonasResearch Results

In a significant step for the treatment of neuroblastoma, an international group of researchers led by Children’s Hospital of Philadelphia (CHOP), Winship Cancer Institute of Emory University and the New Approaches to Neuroblastoma Therapy (NANT) Consortium has shown that the targeted therapy lorlatinib is safe and effective in treating high-risk neuroblastoma.